StockData
Calidi Biotherapeutics, Inc. logo

Calidi Biotherapeutics, Inc. (CLDI) stock

CLDINYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as CLDWW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 3/30
$0.56−0.04 (-7.07%)

Close on Nov 17, 2026Market cap $1.45MP/E –Yield –

Calidi Biotherapeutics total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Calidi Biotherapeutics's total debt was $45.00K at Jun 30, 2026. For fiscal 2025 it was $90.00K, down 97.2% from the year before.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$90.00K-97.2%
FY2024Dec 31, 2024$3.22M+299.1%
FY2023Dec 31, 2023$807.00K-85.1%
FY2022Dec 31, 2022$5.43M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$45.00K-94.5%
Q1 FY2026Mar 31, 2026$23.00K-98.0%
Q4 FY2025Dec 31, 2025$90.00K-97.2%
Q3 FY2025Sep 30, 2025$472.00K-84.8%
Q2 FY2025Jun 30, 2025$820.00K-72.5%
Q1 FY2025Mar 31, 2025$1.16M-72.7%
Q4 FY2024Dec 31, 2024$3.22M+299.1%
Q3 FY2024Sep 30, 2024$3.11M-7.0%
Q2 FY2024Jun 30, 2024$2.98M-45.0%
Q1 FY2024Mar 31, 2024$4.24M–
Q4 FY2023Dec 31, 2023$807.00K–
Q3 FY2023Sep 30, 2023$3.35M–
Q4 FY2022Dec 31, 2022$5.43M–

More Calidi Biotherapeutics figures

See a number that looks wrong?